Stability of 5-acetamido-6-formylamino-3-methyluracil in buffers and urine

Journal of Pharmaceutical and Biomedical Analysis

Volumn 28, Issue 3-4, 2002, Pages 693-700

  Wong, Pierre ^a   Villeneuve, Gérald ^a   Tessier, Vicky ^a   Banerjee, Kris ^a   Nedev, Hinko ^a   Jean Claude, Bertrand J ^a   Leyland Jones, Brian ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

5 Acetamido 6 amino 3 methyluracil; 5 Acetamido 6 formylamino 3 methyluracil; Caffeine; ELISA; HPLC; NAT2 phenotyping; Urine

Indexed keywords

5 ACETAMIDO 6 AMINO 3 METHYLURACIL; 5 ACETAMIDO 6 FORMYLAMINO 3 METHYLURACIL; UNCLASSIFIED DRUG; URACIL DERIVATIVE;

ARTICLE; DRUG HALF LIFE; DRUG STABILITY; DRUG SYNTHESIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IONIZATION; PH; PRIORITY JOURNAL; TEMPERATURE; ULTRAVIOLET SPECTROPHOTOMETRY; URINALYSIS;

BUFFERS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; HALF-LIFE; HYDROGEN-ION CONCENTRATION; INDICATORS AND REAGENTS; KINETICS; SPECTROPHOTOMETRY, ULTRAVIOLET; TEMPERATURE; URACIL;

EID: 0037093680     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0731-7085(01)00656-2     Document Type: Article

References (16)

1. N-acetyltransferase
2. Rapid metabolic phenotypes for acetyltransferase and cytochrome P4501A2 and putative exposure to food-borne heterocyclic amines increase the risk for colorectal cancer or polyps
3. Cigarette smoking, N-acetyltransferase 2 genetic polymorphisms, and breast cancer risk
4. Homozygous rapid arylamine N-acetyltransferase (NAT2) genotype as a susceptibility factor for lung cancer
5. N-acetylation among HIV-positive patients and patients with AIDS: When is fast, fast and slow, slow?
6. A simple test for acetylator phenotype using caffeine
7. Determination of CYP1A2 and NAT2 phenotypes in human populations by analysis of caffeine urinary metabolites
8. Determination of N-acetylator phenotype using caffeine as a probe compound: A comparison of high-performance liquid chromatography and capillary electrophoresis methods
9. Analysis of NAT and CYP1A2 phenotypes and NAT2* genotype by capillary electrophoresis
10. Potential artifacts in the use of caffeine to determine acetylation phenotype
11. Isolation and identification of 5-acetylamino-6-formylamino-3-methyluracil as a major metabolite of caffeine in man
12. Validity of an ELISA for N-acetyltransferase-2 (NAT2) phenotyping
13. NAT2 phenotyping: Characterization of AFMU stability
14. Über die darstellung von 4,5-diamino-pyrimiden
15. A competitive antigen enzyme linked immunosorbent linked assay for the determination of N-acetyltransferase (NAT2) phenotypes
16. A new urinary pyrimidine, 5-acetamido-6-amino-3-methyluracil. Isolation, identification and synthesis